@article{3101506,
    title = "Reply to the letter to the editor 'The ESMO magnitude of clinical benefit scaling tool: From theory to practice' by Hartmann and the letter 'Comment on ESMO magnitude of clinical benefit scale' by Muhonen et al.",
    author = "Cherny, N.I. and Sullivan, R. and Dafni, U. and Kerst, J.M. and Sobrero, A. and Zielinski, C. and De Vries, E.G.E. and Piccart, M.J.",
    journal = "Annals of Oncology",
    year = "2016",
    volume = "27",
    number = "1",
    pages = "203-205",
    publisher = "Oxford University Press",
    issn = "0923-7534, 1569-8041",
    doi = "10.1093/annonc/mdv502",
    keywords = "analytical research;  attitude to health;  biomedical technology assessment;  clinical assessment tool;  clinical benefit scaling tool;  clinical effectiveness;  clinical evaluation;  confidence interval;  health care policy;  health hazard;  health service;  health technology assessment;  human;  Israel;  Letter;  oncology;  overall survival;  practice guideline;  priority journal;  quality of life;  reimbursement;  statistical analysis;  Neoplasms;  outcome assessment;  procedures, Humans;  Neoplasms;  Outcome Assessment (Health Care)"
}